rss

Author index

December 2000, Volume 55, Issue 12

[Front cover][Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. ALLEN, D J

    • Intravenous montelukast Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070a

  2. Alvarez-Lerma, F

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  3. ANTUNES, G

    • Management of malignant pleural effusions Thorax 2000;55:12 981-983 doi:10.1136/thorax.55.12.981

  4. Ayo, D S

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

B

  1. Bauer, T T

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  2. Blanquer, J

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  3. Blum, A

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  4. BRITTON, J

    • Annual report October 1999 to September 2000 Thorax 2000;55:12 986 doi:10.1136/thorax.55.12.986

  5. Brophy, C J

    • How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer Thorax 2000;55:12 1000-1006 doi:10.1136/thorax.55.12.1000

  6. BUCHDAHL, ROGER

    • Spacer devices in asthma Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070

C

  1. Calverley, P M A

    • Capsaicin induced cough in cryptogenic fibrosing alveolitis Thorax 2000;55:12 1028-1032 doi:10.1136/thorax.55.12.1028

  2. Castillo, F

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

D

  1. DaCosta, P

    • Primary pulmonary botryomycosis: a late complication of foreign body aspiration Thorax 2000;55:12 1068-1069 doi:10.1136/thorax.55.12.1068

  2. Diters, R W

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  3. Doherty, M J

    • Capsaicin induced cough in cryptogenic fibrosing alveolitis Thorax 2000;55:12 1028-1032 doi:10.1136/thorax.55.12.1028

E

  1. ELBORN, S

    • Pseudomonas infection in CF
      1. Commentator:
        • S ELBORN
      Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070b

F

  1. Fergusson, W

    • Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack Thorax 2000;55:12 1007-1015 doi:10.1136/thorax.55.12.1007

G

  1. Gardner, W N

    • Hyperventilation and asymptomatic chronic asthma Thorax 2000;55:12 1016-1022 doi:10.1136/thorax.55.12.1016

  2. Garrett, J

    • Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack Thorax 2000;55:12 1007-1015 doi:10.1136/thorax.55.12.1007

  3. Gore, J M

    • How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer Thorax 2000;55:12 1000-1006 doi:10.1136/thorax.55.12.1000

  4. Greenstone, M A

    • How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer Thorax 2000;55:12 1000-1006 doi:10.1136/thorax.55.12.1000

  5. Grimminger, F

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

H

  1. HILL, K M

    • Palliative care for patients with non-malignant end stage respiratory disease Thorax 2000;55:12 979-981 doi:10.1136/thorax.55.12.979

  2. Hosker, H S R

    • Primary pulmonary botryomycosis: a late complication of foreign body aspiration Thorax 2000;55:12 1068-1069 doi:10.1136/thorax.55.12.1068

  3. Hull, J

    • Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families Thorax 2000;55:12 1023-1027 doi:10.1136/thorax.55.12.1023

J

  1. Johnson, S R

    • Clinical experience of lymphangioleiomyomatosis in the UK Thorax 2000;55:12 1052-1057 doi:10.1136/thorax.55.12.1052

K

  1. Kanabar, V

    • Hyperventilation and asymptomatic chronic asthma Thorax 2000;55:12 1016-1022 doi:10.1136/thorax.55.12.1016

  2. KNOX, A J

    • Annual report October 1999 to September 2000 Thorax 2000;55:12 986 doi:10.1136/thorax.55.12.986

  3. Kolbe, J

    • Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack Thorax 2000;55:12 1007-1015 doi:10.1136/thorax.55.12.1007

  4. Kwiatkowski, D

    • Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families Thorax 2000;55:12 1023-1027 doi:10.1136/thorax.55.12.1023

L

  1. Lane, K B

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  2. Leal-Noval, S R

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  3. Lee, Y C G

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  4. León-Gil, C

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  5. Le Souëf, P N

    • Paediatric origins of adult lung diseases • 4: Tobacco related lung diseases begin in childhood Thorax 2000;55:12 1063-1067 doi:10.1136/thorax.55.12.1063

  6. Lewis, A

    • Hyperventilation and asymptomatic chronic asthma Thorax 2000;55:12 1016-1022 doi:10.1136/thorax.55.12.1016

  7. Light, R W

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  8. Lopes-Ribeiro, X

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  9. Lücke, C

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

M

  1. Macfarlane, J T

    • A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales Thorax 2000;55:12 1040-1045 doi:10.1136/thorax.55.12.1040

  2. Martínez-Pellús, A

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  3. MASSIE, JOHN

    • Pseudomonas infection in CF
      1. Commentator:
        • S ELBORN
      Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070b

  4. Mayer, K

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  5. McNeill, Ann

    • Smoking cessation guidelines for health professionals: an update Thorax 2000;55:12 987-999 doi:10.1136/thorax.55.12.987

  6. Mister, R

    • Capsaicin induced cough in cryptogenic fibrosing alveolitis Thorax 2000;55:12 1028-1032 doi:10.1136/thorax.55.12.1028

  7. MUERS, M F

    • Palliative care for patients with non-malignant end stage respiratory disease Thorax 2000;55:12 979-981 doi:10.1136/thorax.55.12.979

N

  1. Nadal, P

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  2. NEVILLE, E

    • Management of malignant pleural effusions Thorax 2000;55:12 981-983 doi:10.1136/thorax.55.12.981

O

  1. O'Connor, B J

    • Hyperventilation and asymptomatic chronic asthma Thorax 2000;55:12 1016-1022 doi:10.1136/thorax.55.12.1016

  2. Olschewski, H

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  3. Osborne, C A

    • Hyperventilation and asymptomatic chronic asthma Thorax 2000;55:12 1016-1022 doi:10.1136/thorax.55.12.1016

P

  1. Palomar, M

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  2. Parker, R E

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  3. Pearson, M G

    • Capsaicin induced cough in cryptogenic fibrosing alveolitis Thorax 2000;55:12 1028-1032 doi:10.1136/thorax.55.12.1028

R

  1. Raw, Martin

    • Smoking cessation guidelines for health professionals: an update Thorax 2000;55:12 987-999 doi:10.1136/thorax.55.12.987

  2. ROBERTS, S A

    • Obtaining tissue from the mediastinum: endoscopic ultrasound guided transoesophageal biopsy Thorax 2000;55:12 983-985 doi:10.1136/thorax.55.12.983

  3. Rogers, J T

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  4. ROSEBY, ROB

    • Pseudomonas infection in CF
      1. Commentator:
        • S ELBORN
      Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070b

  5. Ros, F

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

S

  1. Schmidt, D

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  2. Schulz, R

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  3. Seeger, W

    • Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy Thorax 2000;55:12 1046-1051 doi:10.1136/thorax.55.12.1046

  4. Simpson, J C G

    • A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales Thorax 2000;55:12 1040-1045 doi:10.1136/thorax.55.12.1040

  5. SINGH, S D

    • Intravenous montelukast Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070a

  6. SUMMERFIELD, ALISON

    • Spacer devices in asthma Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070

T

  1. Tattersfield, A E

    • Clinical experience of lymphangioleiomyomatosis in the UK Thorax 2000;55:12 1052-1057 doi:10.1136/thorax.55.12.1052

  2. Thompson, P J

    • Transforming growth factor β2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications Thorax 2000;55:12 1058-1062 doi:10.1136/thorax.55.12.1058

  3. Thomson, A

    • Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families Thorax 2000;55:12 1023-1027 doi:10.1136/thorax.55.12.1023

  4. Torres, A

    • Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin Thorax 2000;55:12 1033-1039 doi:10.1136/thorax.55.12.1033

  5. Tuggey, J M

    • Primary pulmonary botryomycosis: a late complication of foreign body aspiration Thorax 2000;55:12 1068-1069 doi:10.1136/thorax.55.12.1068

V

  1. Vamos, M

    • Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack Thorax 2000;55:12 1007-1015 doi:10.1136/thorax.55.12.1007

W

  1. WARD, SIMON

    • Spacer devices in asthma Thorax 2000;55:12 1070 doi:10.1136/thorax.55.12.1070

  2. Watson, J

    • A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales Thorax 2000;55:12 1040-1045 doi:10.1136/thorax.55.12.1040

  3. West, Robert

    • Smoking cessation guidelines for health professionals: an update Thorax 2000;55:12 987-999 doi:10.1136/thorax.55.12.987

  4. Woodhead, M A

    • A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales Thorax 2000;55:12 1040-1045 doi:10.1136/thorax.55.12.1040

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.